Similar Articles
1301 Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection
1302 Biomarkers for the early diagnosis of hepatocellular carcinoma
1303 Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
1304 Does herbal medicine reduce the risk of hepatocellular carcinoma?
1305 Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation
1306 Potentiality of immunotherapy against hepatocellular carcinoma
1307 Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
1308 Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
1309 Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice
1310 Liver resection for hepatocellular carcinoma using a microwave tissue coagulator: Experience of 1118 cases
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA